Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in semiconductor chip fabrication. It operates in the United States, Europe, and the Asia Pacific, offering high energy, high current, and medium current implanters for various application requirements. The company also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Its equipment and services are sold to semiconductor chip manufacturers through a direct sales force. Founded in 1978, Axcelis Technologies is headquartered in Beverly, Massachusetts.
Axcelis to Build $35 Million Ion Implantation Factory in Korea
Axcelis Technologies announced a $35 million investment in a new ion implantation equipment factory in Pyeongtaek, Gyeonggi Province, Korea, with a groundbreaking planned for October 20 and output not scheduled until the back half of 2028. The roughly 200,000-square-foot site will include warehousing, a training center, and two grades of cleanrooms, and CEO Russell Low framed it as an extension of Axcelis' existing Korean presence meant to serve rising global semiconductor demand; Executive Vice President Robert Mahoney took part in an investment declaration ceremony in Washington, D.C., alongside Korean trade officials. The move follows the company's August 6, 2026 second-quarter report, in which revenue rose from a year earlier and beat its own forecasts on stronger system shipments and aftermarket business, with Axcelis guiding to roughly $230 million in third-quarter sales and expecting revenue growth in 2026 that carries into 2027. Even so, GAAP earnings per share fell to $0.75 from $0.98 a year earlier and gross margin slid to 42.4% from 44.9%. Axcelis also has a pending merger with Veeco still awaiting remaining conditions, targets a close in the second half of 2026, and is operating with an interim CFO, while 33 hedge funds held the stock in the most recent quarter, up from 25, and short interest stands at 6.70% of the float.
Axcelis Eyes Mid-Single-Digit 2026 Revenue Growth as Veeco Merger Awaits China Approval
Axcelis Technologies is pointing to renewed growth as memory, power and aftermarket demand improve, with management expecting full-year 2026 revenues to grow at a mid-single-digit rate and further growth in 2027. The Zacks Consensus Estimate calls for 2027 revenues of $981 million and earnings of $5.29 per share, versus $884 million and $4.12 expected for 2026. Customer Solutions & Innovation revenues increased 35.1% year over year to $82.8 million in the second quarter of 2026, up 14% sequentially from $72.6 million. Second-quarter non-GAAP gross margin was 42.7%, down from 45.2% a year earlier, and non-GAAP operating margin fell to 14.7% from 17.7%, even as revenues rose 10.6% year over year. Axcelis trades at 21.2X forward 12-month earnings, above the Zacks industry multiple of 20.0X and its five-year median of 18.6X, and its pending all-stock combination with Veeco Instruments still depends on regulatory approval from China's State Administration for Market Regulation after shareholders approved the related share issuance in February 2026.
Semiconductors › Deposition, Etch & Process Tools ▲Demand
ACLS · Capital · Negative Second-quarter non-GAAP gross margin fell to 42.7% from 45.2% and operating margin dropped to 14.7% from 17.7%.
ACLS · Demand · Positive Axcelis expects mid-single-digit 2026 revenue growth on improving memory, power and aftermarket demand, with Customer Solutions & Innovation revenue up 35.1% YoY.
VECO · Regulation · Neutral Veeco's pending all-stock merger with Axcelis still awaits regulatory approval from China's State Administration for Market Regulation.
Axcelis to Invest $35 Million in New South Korea Manufacturing Facility
Axcelis Technologies plans to invest $35 million in a new ion implantation equipment facility in Pyeongtaek, Gyeonggi Province, South Korea. The planned site will span approximately 200,000 square feet and include warehousing, Class 1,000 and Class 10,000 cleanrooms and a training center, building on the company's existing Asia Operations Center in the country. South Korea generated 26% of second-quarter revenues, up from 13% a year earlier, making it the company's second-largest revenue region after China. Systems bookings increased 36.1% year over year to $130.9 million in the second quarter, while systems backlog was $451.6 million, down 21.6% from $575.7 million a year earlier. Axcelis ended the second quarter with $577 million in cash, cash equivalents and marketable securities, and free cash flow of $14.8 million included about $6 million of cash transaction expenses related to the pending Veeco merger.
Semiconductors › Deposition, Etch & Process Tools Capital
ACLS · Capital · Positive Axcelis plans a $35M investment in a new South Korea ion implantation equipment facility, expanding capacity in its second-largest revenue region.
Axcelis to Build $35M Manufacturing Facility in Pyeongtaek, Korea
Axcelis Technologies, Inc. (Nasdaq: ACLS) announced plans to invest $35 million in a new ion implantation equipment manufacturing facility in Pyeongtaek, Gyeonggi Province, Korea, as part of its global manufacturing expansion. The facility will span approximately 200,000 square feet and include warehousing, cleanrooms, and a training center, with production slated to begin in the second half of 2028. President and CEO Russell Low said the investment underscores Axcelis' commitment to supporting global semiconductor demand. The announcement follows an Investment Declaration Ceremony in Washington, D.C., with Korean trade officials, and a groundbreaking is scheduled for October 20, 2026.
Semiconductors › Deposition, Etch & Process Tools Capital
ACLS · Capital · Positive Axcelis announces a $35M investment in a new ion implantation equipment manufacturing facility in Pyeongtaek, Korea, expanding its global manufacturing capacity.
Axcelis Q2 revenue beats forecast, raises full-year outlook
Axcelis Technologies reported second-quarter revenue of $215.2 million and non-GAAP diluted earnings per share of $1.06, both above company forecasts, and raised its full-year 2026 revenue growth outlook to approximately mid-single digits from a prior expectation of flat performance. Systems revenue was $132 million, supported by recovery in power markets and general mature node activity, while CS&I revenue grew sequentially to $83 million on higher customer utilization. Bookings were $131 million with a book-to-bill ratio of approximately 1x over the past three quarters, and backlog stood at $452 million. The company guided third-quarter revenue of approximately $230 million and non-GAAP diluted EPS of $1.11, and expects the pending merger with Veeco Instruments to close in the second half of 2026.
Veeco lifts 2026 revenue outlook to $780M-$810M, plans to double advanced packaging and silicon photonics capacity in 2027
Veeco Instruments updated its full-year 2026 revenue guidance to a range of $780 million to $810 million and announced plans to more than double its capacity in advanced packaging and silicon photonics during 2027. CEO William Miller said the company sees an important inflection point driven by AI investments, with order momentum accelerating across all major end markets, including $200 million in advanced packaging orders for wet processing and lithography systems that strengthen visibility into 2027. CFO John Kiernan reported second-quarter revenue of $193 million and non-GAAP diluted earnings per share of $0.33, with semiconductor revenue reaching $131 million, an increase of 20% from the prior quarter. The company expects the capacity expansion to pressure near-term profitability, with approximately $10 million in incremental operating expenses and a roughly 75-basis-point impact on full-year gross margin. Veeco also provided third-quarter revenue guidance of $200 million to $220 million and non-GAAP diluted EPS of $0.35 to $0.49, while noting that the pending merger with Axcelis has secured all regulatory clearances except for China antitrust approval and remains on track to close in the second half of 2026.
Axcelis Stock Doubles This Year on AI Memory Demand and Veeco Merger
Axcelis Technologies' stock price has more than doubled year to date, driven by its role in ion-implantation equipment for AI chip fabrication. The company reported only 3% year-over-year revenue growth in Q1, but that was due to declining sales in Power and General Mature markets, while memory demand fueled strong sequential growth in its customer support and innovation segment. The upcoming merger with Veeco Instruments, whose stock has also more than doubled this year, is expected to close in the second half and could expand market share through complementary AI infrastructure equipment like laser annealing. With the memory industry remaining hot, as evidenced by Micron Technology's recent earnings, investors are anticipating that memory will become a larger share of Axcelis' revenue, potentially driving growth in 2027.
South Korea
United States